Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are...

Area of Science:

• Pharmacology
• Critical Care Medicine
• Physiology

Background:

• Short-acting beta-blockers may benefit sepsis patients by decreasing heart rate.
• However, potential risks include hemodynamic depression and reduced cerebral oxygenation in endotoxemia.

Purpose of the Study:

• To investigate the hemodynamic and cerebral oxygenation effects of landiolol during different stages of endotoxemia in a swine model.
• To assess the impact of landiolol on stroke volume, cardiac output, and tissue oxygenation index (TOI).

Main Methods:

• Seventeen swine were divided into landiolol and control groups.
• Landiolol was administered at increasing doses (0-200 μg/kg/min) before and during two stages of endotoxemia induced by lipopolysaccharide (LPS).
• Hemodynamics and cerebral TOI were monitored using near-infrared spectroscopy.

Main Results:

• LPS increased heart rate; landiolol consistently decreased it.
• In early endotoxemia, landiolol maintained stroke volume and cardiac output.
• In later endotoxemia, landiolol failed to restore stroke volume, leading to decreased cardiac output and TOI.

Conclusions:

• Short-acting beta-blockers have complex hemodynamic effects in endotoxemia.
• Landiolol's utility in sepsis may be limited by its potential to reduce cerebral oxygenation when hemodynamics are compromised.